Feedback / Questions
berubicin (RTA 744) - CNS Pharma, WPD Pharma
https://www.prnewswire.com/news-releases/cns-pharmaceuticals-announces-preliminary-results-from-ongoing-potentially-pivotal-trial-evaluating-berubicin-for-the-treatment-of-recurrent-glioblastoma-multiforme-gbm-301698357.html
Dec 8, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next